Your session is about to expire
← Back to Search
Hydrochlorothiazide for Postpartum Hypertension
Study Summary
This trial found that postpartum prophylactic administration of hydrochlorothiazide (HCTZ) may be effective in preventing relapse of preeclampsia or gestational hypertension.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many patients are enrolled in this research project?
"That is correct. The listing on clinicaltrials.gov confirms that this study, which was first advertised on November 21st 2017, is still recruiting patients. They are looking for 612 people to participate at 3 different locations."
What are some of the dangers associated with taking Hydrochlorothiazide 50mg Tablet?
"Hydrochlorothiazide 50mg Tablet is classified as a Phase 3 drug, meaning that there is both efficacy and safety data available. Our team has rated its safety as a 3 out of 3."
Are any slots still available for participants in this trial?
"Indeed, the clinical trial is still open and recruiting patients. According to the information on clinicaltrials.gov, the study was first posted on 11/21/2017, with the most recent update being made 8/18/2022. They are looking for 612 participants total, which will be recruited from 3 sites."
What is the goal of this clinical trial?
"The primary outcome of this study, which will take place in the 6 weeks post-partum, is the Need for additional antihypertensive therapy. Additionally, we will measure Use of resources (hospital stay, postpartum clinic or emergency room visit within 4-6 weeks of delivery, need for imaging or other invasive procedures), Total Additional doses of anti-hypertensive therapy (addition of total doses that patient received in the postpartum period), and Length of hospital stay (days that patient required to be in-house in the postpartum period) as secondary outcomes."
Can I join this clinical trial?
"The ideal candidate for this study is a woman aged 18-50 who has been diagnosed with pre-eclampsia. A total of 612 participants are needed."
What are some common reasons why people take Hydrochlorothiazide 50mg Tablets?
"Hydrochlorothiazide 50mg Tablet is often used to counteract sodium retention, but it can also be helpful in managing edema, when other therapies have been ineffective, and for patients who do not respond well to blood pressure medication."
Are there other research papers that focus on Hydrochlorothiazide 50mg Tablet?
"There are currently 12 ongoing clinical trials studying the effects of Hydrochlorothiazide 50mg Tablets. 5 of those trials are in their third and final phase. Most of the trial locations for this medication are centred around Kansas City, Kansas; though, there are 80 total locations running these studies."
If a septuagenarian meets the other requirements, are they eligible for this research project?
"The parameters for this study only allow patients aged 18 to 50. However, there are 66 other clinical trials for minors and 739 for seniors."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger